Your browser doesn't support javascript.
loading
Eliminating roles for T-bet and IL-2 but revealing superior activation and proliferation as mechanisms underpinning dominance of regulatory T cells in tumors.
Colbeck, Emily J; Hindley, James P; Smart, Kathryn; Jones, Emma; Bloom, Anja; Bridgeman, Hayley; McPherson, Rhoanne C; Turner, Darryl G; Ladell, Kristin; Price, David A; O'Connor, Richard A; Anderton, Stephen M; Godkin, Andrew J; Gallimore, Awen M.
Afiliação
  • Colbeck EJ; Institute of Infection Immunity and Biochemistry, Cardiff University School of Medicine, Cardiff, CF14 4XN, UK.
  • Hindley JP; Institute of Infection Immunity and Biochemistry, Cardiff University School of Medicine, Cardiff, CF14 4XN, UK.
  • Smart K; Institute of Infection Immunity and Biochemistry, Cardiff University School of Medicine, Cardiff, CF14 4XN, UK.
  • Jones E; Institute of Infection Immunity and Biochemistry, Cardiff University School of Medicine, Cardiff, CF14 4XN, UK.
  • Bloom A; Institute of Infection Immunity and Biochemistry, Cardiff University School of Medicine, Cardiff, CF14 4XN, UK.
  • Bridgeman H; Institute of Infection Immunity and Biochemistry, Cardiff University School of Medicine, Cardiff, CF14 4XN, UK.
  • McPherson RC; MRC Centre for Inflammation Research, Centre for Multiple Sclerosis Research and Centre for Immunity Infection and Evolution, University of Edinburgh, Edinburgh EH16 4TJ, UK.
  • Turner DG; MRC Centre for Inflammation Research, Centre for Multiple Sclerosis Research and Centre for Immunity Infection and Evolution, University of Edinburgh, Edinburgh EH16 4TJ, UK.
  • Ladell K; Institute of Infection Immunity and Biochemistry, Cardiff University School of Medicine, Cardiff, CF14 4XN, UK.
  • Price DA; Institute of Infection Immunity and Biochemistry, Cardiff University School of Medicine, Cardiff, CF14 4XN, UK.
  • O'Connor RA; MRC Centre for Inflammation Research, Centre for Multiple Sclerosis Research and Centre for Immunity Infection and Evolution, University of Edinburgh, Edinburgh EH16 4TJ, UK.
  • Anderton SM; MRC Centre for Inflammation Research, Centre for Multiple Sclerosis Research and Centre for Immunity Infection and Evolution, University of Edinburgh, Edinburgh EH16 4TJ, UK.
  • Godkin AJ; Institute of Infection Immunity and Biochemistry, Cardiff University School of Medicine, Cardiff, CF14 4XN, UK.
  • Gallimore AM; Institute of Infection Immunity and Biochemistry, Cardiff University School of Medicine, Cardiff, CF14 4XN, UK.
Oncotarget ; 6(28): 24649-59, 2015 Sep 22.
Article em En | MEDLINE | ID: mdl-26433463
ABSTRACT
Foxp3(+) regulatory T cells (Tregs) are often highly enriched within the tumor-infiltrating T cell pool. Using a well-characterised model of carcinogen-induced fibrosarcomas we show that the enriched tumor-infiltrating Treg population comprises largely of CXCR3(+) T-bet(+) 'TH1-like' Tregs which are thymus-derived Helios(+) cells. Whilst IL-2 maintains homeostatic ratios of Tregs in lymphoid organs, we found that the perturbation in Treg frequencies in tumors is IL-2 independent. Moreover, we show that the TH1 phenotype of tumor-infiltrating Tregs is dispensable for their ability to influence tumor progression. We did however find that unlike Tconvs, the majority of intra-tumoral Tregs express the activation markers CD69, CD25, ICOS, CD103 and CTLA4 and are significantly more proliferative than Tconvs. Moreover, we have found that CD69(+) Tregs are more suppressive than their CD69- counterparts. Collectively, these data indicate superior activation of Tregs in the tumor microenvironment, promoting their suppressive ability and selective proliferation at this site.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma Experimental / Ativação Linfocitária / Linfócitos do Interstício Tumoral / Interleucina-2 / Linfócitos T Reguladores / Proteínas com Domínio T / Proliferação de Células / Fibrossarcoma Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma Experimental / Ativação Linfocitária / Linfócitos do Interstício Tumoral / Interleucina-2 / Linfócitos T Reguladores / Proteínas com Domínio T / Proliferação de Células / Fibrossarcoma Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2015 Tipo de documento: Article